2022
DOI: 10.26442/00403660.2022.06.201743
|View full text |Cite
|
Sign up to set email alerts
|

New opportunities for neuroprotective therapy of patients in the acute and early recovery period of ischemic stroke

Abstract: Aim. To evaluate the efficacy and safety of Brainmax in comparison with ethylmethylhydroxypyridine succinate and trimethylhydrazinium propionate in patients with ischemic stroke in the acute and early recovery period. Materials and methods. An open multicenter randomized study included 180 patients aged 1880 years (mean age 60.917.66 years, men 47.8%) with ischemic stroke in the acute and early recovery period (NIHSS from 3 to 15 points). Patients were randomized to receive Brainmax, ethylmethylhydroxypy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
references
References 8 publications
(3 reference statements)
0
0
0
Order By: Relevance